SBRA Stock Forecast & Price Target

Sabra Health Care REIT is supported by improving fundamentals across its skilled nursing and senior housing portfolio, with 2026 guidance raised to normalized AFFO per share of $1.59-$1.61 and normalized FFO of $1.53-$1.55 on the back of stronger operating trends. Its outlook is further strengthened by re-leasing all 26 Avamere properties at about a 30% premium to trailing cash rent, more than $9 million of incremental annual cash NOI from other portfolio actions, and a $200 million RCA mortgage resolution that helps de-risk the balance sheet. With SHOP expected to reach 40% of gross assets by FYE26, 2Q26 SHOP acquisitions closed at a 7.9% initial cash yield, and U.S. senior housing occupancy at 89.9% in 2Q26, the company appears positioned for durable internal growth and covered dividend support.

Sabra Health Care REIT is pressured by a fragile operating model that depends heavily on tenant performance, government reimbursement, and regulatory compliance, any of which can impair lease collections if operators face weaker margins, license issues, or reduced Medicaid and Medicare funding. Its reliance on external capital and significant debt levels heighten refinancing and funding risk, while intense REIT competition and re-leasing uncertainty could compress returns and make future acquisitions less accretive. Near-term fundamentals also look softer after RCA repaid a $300 million mortgage with only $200 million, raising dilutive pressure on FFO estimates, alongside a $9 million increase in FY26 G&A guidance to $61 million and the risk that lease coverage and senior housing performance weaken further.